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Abstract

The use of selective serotonin reuptake inhibitors

(SSRIs)

is rapidly growing among the general population.
Researchers have identified only minimal empirical data
regarding the SSRI-prescribing practices among primary
care providers. The focus of this descriptive study was to
explore SSRI-prescribing practices of primary care
providers. Benner's

(1984) Novice to Expert Model was the

theoretical framework used to conduct this study. The
research questions used to guide the research were as
follows:

What factors influence the prescribing practices

of primary care providers regarding SSRIs? And what are
the perceived competency levels of primary care providers
in prescribing SSRIs? The research design was a
nonexperimental, descriptive design. A convenience sample
of all primary care providers in a rural area was
utilized. Data were obtained through a self-report survey
using a researcher-developed demographic survey and the
Dowell Prescribing Practice Questionnaire.
analyzed using descriptive statistics,

Data were

and content

analysis was used for any open-ended questions. The sample

111

consisted of 30 primary care providers. The study found
that the most prescribed antidepressants were SSRIs.
Lexapro was the most often prescribed, while Luvox was the
SSRI least often prescribed. Side effects were the most
influential factor in choosing an SSRI. The majority of
respondents do not recommend any other type of treatment
before prescribing an antidepressant. Of the respondents
who do prescribe another type of treatment, professional
counseling and exercise were recommended most often.
Overall, the majority of respondents felt very competent
prescribing SSRIs as well as answering patients' questions
related to SSRIs. Recommendations for further research
included replication of the study with a larger, more
diverse sample of primary care providers and conducting
research using participants who have been prescribed an
SSRI.

IV

Dedication

This research is dedicated

to my brother, Billy,

who has given me love, strength, and
support throughout this year and
always.

V

Acknowledgments
First and foremost,

I would like to thank God for

giving me the ability to complete this program.

I could

not have accomplished this without him nor have the
blessings that I have in my life. I thank him for always
loving me and being by my side.
To my wonderful parents, thank you for always loving
me so much.

I appreciate your never-ending support,

encouragement,

and generosity.

I am so lucky and proud to

be your

daughter. It has been by your

examples that Icare

so much

for other people. I can only hope

that I will

touch the lives of others throughout my career as you both
do in your profession.

I love and appreciate you both more

than you will ever know.
To

Billy and Meredith, thank you

encouragement and

prayers. Billy, you

for
are

all of your
the best brother

in the world and I am so lucky to be your sister. Thank
you both for having so much faith in me. Meredith,

thank

you for taking such good care of Billy during his illness.
It comforted me to know that he was in such loving and
caring hands.

I love you both so much.

VI

To Jay, thank you for all that you have done to make
this year possible. Thank you for having so much faith in
me and for loving me so much. You were always there to
encourage me when I needed it the most.

I could not have

completed this program without you. I am the luckiest girl
in the world to have someone so kind, giving, patient, and
understanding. Thank you for being so supportive of my
dreams.

I love you so much and I can't wait to spend my

life with you.
To Mr. John, Mrs. Faye, Ty, Tammy, Robert,

and

Candace, thank you for all of your encouragement and
prayers.

I am so lucky to be a part of such a supportive

family. You have all helped make this year possible.

I

love you all.
To Allison, Amy Jo, Dena, Emily, Jimmy D . , and Leigh,
thank you for truly being so proud of me. You are the best
friends in the world. Thanks for always listening and for
always being there for me. I love each of you.
To Heather McFarland, thank you for being my
preceptor.

I am very thankful that our paths crossed.

Thank you for all that you taught me, but most of all for
being such a great friend.

I appreciate you always

listening and being so supportive.

VI1

To Dr. Thom Davis, thank you for all that you did to
make this year possible. Your kindness and support will
never be forgotten. Thank you for believing in me.
To the MUW class of 2003, I will never forget any of
you. I was blessed to be a part of this group of caring,
loving, and supportive individuals. Thank you for being a
part of my dream, but most of all for your friendship.
I would like to thank Terri Hami11, my committee
chair,

for her encouragement and direction during the

preparation and writing of this thesis. I would also like
to thank Dr. Melinda Rush, committee member,
contributions to this study.

Vlll

for her

Table of Contents
Page
A b s t r a c t ..............................................
Dedication

............................................

iii
v

A c k n o w l e d g m e n t s .......................................

vi

List of T a b l e s .......................................

xi

Chapter
I.

II.

III.

The Research Problem ..........................

1

Establishment of the Problem ..................
Significance to Nursing
......................
Theoretical Framework
........................
Novice .....................................
Advanced beginner
........................
Competent
.................................
Proficient .................................
Expert .....................................
A s s u m p t i o n s ...................................
Statement of the P r o b l e m ......................
Research Questions ............................
Definition of T e r m s ..........................
S u m m a r y .......................................

2
5
7
7
8
8
9
9
10
10
11
11
13

Review of the L i t e r a t u r e ......................

14

S u m m a r y .......................................

36

The M e t h o d .....................................

37

Design of the S t u d y ..........................
Setting, Population, and Sample
.............
I n s t r u m e n t a t i o n ...............................
Data Collection Procedure
....................
Data Analysis
..........................
S u m m a r y .......................................

37
37
38
39
40
40

ix

IV.

The F i n d i n g s ....................................

42

Description of the S a m p l e ...................
Findings Related to the Research
Q u e s t i o n s .................................
Additional Findings
..........................
S u m m a r y .......................................

42
44
51
52

The O u t c o m e s ....................................

53

Summary of F i n d i n g s ..........................
D i s c u s s i o n .....................................
C o n c l u s i o n s ...................................
Implications for Nursing.......................
E d u c a t i o n .................................
P r a c t i c e ...................................
T h e o r y .....................................
R e s e a r c h ...................................
L i m i t a t i o n s ...................................
Recommendations for Further S t u d y ............

54
55
58
59
59
60
60
61
61
62

R e f e r e n c e s ............................................

63

V.

Appendix
A.

Demographic Survey .............................

B.

Dowell Prescribing Practice Questionnaire

C.

Approval of Committee on Use of Human
Subjects in Experimentation of
Mississippi University forWomen
...........

72

Letter of Introduction andInformed
C o n s e n t .....................................

74

Follow-up Postcard .............................

76

D.
E.

X

.

66
.

68

List of Tables
Table
1.

2.

3.

4.
5.
6.

7.

Page
Demographic Data Reported by Primary
Care Providers Expressed in Frequency
and P e r c e n t a g e .................................
Patients Seen Per Day by Primary Care
Providers Expressed in Frequency and
P e r c e n t a g e ...............................

44

Most Common Methods Used to Diagnose
Depression Expressed in Frequency and
P e r c e n t a g e ...............................

45

Percentage of Patients Treated with an
SSRI Expressed in Frequency andPercentage

. .

Frequently Prescribed SSRIs Expressed in
Frequency and Percentage ......................
Factors Influencing the SSRI-Prescribing
Practices of Primary Care Providers
Expressed in Frequency and Percentage . . . .
Treatments Prescribed for the Treatment
of Depression by Primary Care Providers
Other Than Medication Expressed in
Frequency and Percentage ......................

XI

43

46
47

48

49

Chapter I
The Research Problem
Antidepressants are among the most commonly
prescribed drugs in the world. Between 1990 and 1995, new
or continued antidepressant prescriptions increased
approximately 73%, and primary care office visits for
depression doubled between 1988 and 1994

(Shell, 2001) .

The introduction of selective serotonin reuptake
inhibitors

(SSRIs) has brought about many changes in the

treatment of depression and to the prescribing practices
of health care providers.

It is believed that the

development of SSRIs in 1988 may have contributed to these
patterns because of their favorable side effects and
safety profiles

(Stafford, MacDonald,

& Finkelstein,

2 0 0 1 ).

As the use of antidepressants, especially SSRIs,
continues to grow in the primary care setting, more and
more primary care providers will be involved in the
treatment of depression. Minimal research has been
identified regarding the SSRI-prescribing practices of
primary care providers. The purpose of this study was to
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examine the SSRI-prescribing practices among primary care
providers in a southeastern state of the United States.
Establishment of the Problem
Selective serotonin reuptake inhibitors

(SSRIs)

one of several categories of antidepressants.

is

Since their

introduction in the late 1980s, SSRIs have become one of
the most widely prescribed classes of drugs
Jiwanlal,

(Weitzel &

2001). Although most antidepressants are equally

effective in reversing depression in outpatients,

SSRIs

have become the initial drug of choice because they act at
fewer neurotransmitter sites, produce fewer adverse side
effects, and therefore are tolerated better by patients
(Solnek & Seiter, 2002).
Lewis

(2000) reported that nonpsychiatric providers

see three fourths of patients treated in family practice
clinics for depression. This increases the need for
providers to be highly effective in the diagnosing and
treating of depression.
Zwillich

(1999) reported that the number of doctor

office visits including an antidepressant prescription
more than doubled between 1985 and 1994 to more than 24
million. According to Zwillich (1999), researchers
attribute the increase in prescriptions for
antidepressants to the growing popularity of SSRIs.
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Ferguson

(2001) reported the shift of depression

management to primary care practitioners who manage heavy
patient schedules across all therapeutic areas has created
the need to enhance the successful treatment of depression
by adapting new therapeutic strategies. The primary care
provider must be competent in diagnosing depression and
prescribing the treatment that will lead the client to
optimal health.

Ferguson

(2000) reported that nearly 15%

of patients who seek help for their depressive illness and
are left untreated commit suicide within one month of
being seen by a physician. Thus, early and accurate
diagnosis of depressive disorders is an important part of
the primary care provider's evaluation of every patient.
Ferguson

(2001) also reported that the informed

management of side effects by primary care practitioners
supports successful treatment of depression.

Primary care

providers must be knowledgeable of the possible side
effects and adverse reactions of SSRIs in order to safely
prescribe them. The education of their clients regarding
SSRIs also depends on the competence of the prescriber.
With the increased use of these medications,
prescribing practices of clinicians must reach a level
that demonstrates expertise regarding the prescribing of
SSRIs. Prescribers must be knowledgeable of the medication
that they prescribe. They also must have an awareness of

4
the factors that affect their choice of medication or
treatment. Essock

(2002) researched antipsychotic

prescribing practices. The researcher found the relative
frequency of use of the various antipsychotic medications
does not correspond to what is known about their relative
effectiveness for the treatment of schizophrenia. This
leads one to ask how much prescribing patterns are
influenced by pricing, order of introduction,
prescribers'

ease of use,

idiosyncratic beliefs, marketing efforts,

local cultures, and other factors beyond medication
effectiveness

(Essock, 2002). The researcher determined

the variation of prescribing practices was widespread.
Essock

(2002) recommended that guidelines and performance

monitoring must be implemented to reveal the influences
that are defining one's prescribing practices.
Shell

(2001) conducted a study concerning the

antidepressant prescribing practices of nurse
practitioners in the primary care setting. About one third
of the patients seen weekly in the study were suffering
from mental health conditions. This finding was equivalent
to other findings suggesting that primary care providers
are diagnosing and treating mental health disorders
(Shell, 2001). According to Shell

(2001), several findings

conflict with established practice guidelines for the
selection and prescribing of antidepressants,

including
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the antidepressants prescribed most often, antidepressant
selection criteria, and the average length of
antidepressant therapy. Shell

(2001) recommended the need

for further education of nurse practitioners regarding
antidepressant therapy as they are seeing an increasing
number of mental health disorders in the primary care
setting.
Researchers have identified only minimal empirical
data of the prescribing practices of primary care
providers in regard to SSRIs. This information is needed
due to the growing use of SSRIs in the primary care
setting. Primary care providers strongly impact the
patient's outcome by implementing their individual
prescribing practices.

Patients must sense the expertise

of their health care provider in diagnosing depression.
Patients also must perceive that their health care
provider is competent in prescribing SSRIs in the primary
care setting. These data will lead to optimal diagnosing
and treatment of depression.
Significance to Nursing
The current study has several implications for the
primary care provider. Findings from this study will add
to the small amount of research previously conducted
regarding use of SSRIs in primary care practice. The
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paucity of information in the literature regarding SSRIprescribing practices of primary care providers has led to
earnest inquiry concerning the competency of the
prescribers. The findings of this study will add to the
literature regarding the competence of primary care
providers who prescribe SSRIs in their practice setting.
This study explored the use of alternative forms of
treatment and the methods that the primary care provider
takes to arrive at the idea that a patient is suffering
from depression.
This study will support the education of primary care
providers in the prescribing of SSRIs. Non-psychiatric
providers see three fourths of patients treated in family
practice clinics for depression

(Lewis, 2000). Therefore,

it is crucial that all primary care providers are
effective in diagnosing and treating of depression.
Findings from this study may indicate a need for
increasing the amount of time spent on prescribing
medications,

such as SSRIs, in pharmacology courses. As

the use of SSRIs continues to escalate, an increased
knowledge base concerning SSRIs will be necessary in both
medical and nursing schools in order to give patients
optimal care.
The use of SSRIs related to nursing practice is also
of importance.

In addition to increased knowledge
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concerning SSRIs in primary care practice, this study may
encourage those in primary care to evaluate their
competency in prescribing SSRIs. Awareness regarding the
benefits and contraindications of prescribing SSRIs in
primary care may lead to safer clinical practices. This
gain in knowledge also may contribute to the development
of protocols regarding the prescribing of SSRIs in the
primary care setting.
Theoretical Framework
The theoretical framework for this study was Benner's
(2001) Novice to Expert Model. Benner applied a model of
skill acquisition to nursing practice. The model is
composed of five levels that nurses experience to attain
expertise in the field of nursing. These five levels of
skill include novice, advanced beginner,
proficient,

competent,

and expert. These levels also are applicable

to physicians.
Novice. A novice is a beginner. The beginner has not
experienced the situation that he or she is expected to
perform. A novice can be related to the primary care
provider who is not familiar with SSRI-prescribing
practices because of a lack of exposure to the client
population that would require an SSRI. The novice.
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therefore,

remains innocent of possessing prescribing

practices of SSRIs.
Advanced beginner. The advanced beginner requires
prior experience of the situation. He or she must have
grasped the meaningful aspects of the situation. After
being exposed to these aspects, he or she should be
capable of displaying the amateur abilities in a
situation.

Primary care providers learn about prescribing

SSRIs throughout their education preparation. They
continue to learn about the process of prescribing SSRIs
throughout the establishment of their career as they are
exposed to patients meeting criteria that warrant an SSRI.
At this level, the primary care provider begins to impact
the client's care through increased knowledge and
experience. They begin to relay what they have learned to
their client.
Competent. Competence is exemplified by the primary
care provider who has been working in the same situation
or setting for 2 to 3 years. At this level, the primary
care provider can implement a plan for the patient after
contemplating the problem. The primary care provider is
also conscious of long-term goals. This level is
consistent with the process of primary care providers
being aware of their personal prescribing practices of
SSRIs and the factors that influence the practices.
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Proficient. At the proficient level, the primary care
provider learns through experience what outcome to expect
in relation to different situations. As the primary care
provider anticipates the outcome of a certain situation,
he or she also is capable of originating a plan to aid in
dealing with the issue at hand. A primary care provider at
the proficient level would be able to look at the patient
holistically and begin to develop a plan of care in
accordance with the signs and symptoms that the patient is
presenting.

In relation to this study, a primary care

provider at this level would be confident in diagnosing
depression and would begin to incorporate his or her
knowledge of SSRIs to the patient's plan of care.
Expert. The expert no longer depends on analytical
decision making. After many years of experience, the
expert has the ability to zero in on the problem at hand
through intuition. This avoids dissipated considerations
of alternative diagnosis and treatment options. Primary
care providers prescribing SSRIs for their clients at this
level are aware of their personal prescribing practices
and the factors that influence them. They are able to
prescribe an SSRI when they deem it is appropriate for the
diagnosis they have devised. As primary care providers
attain this level of SSRI prescribing, their practices
have a direct impact on the outcome of the patient.
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The focus of Novice to Expert was the process of
ultimately gaining the knowledge and experience needed to
become a confident and competent primary care provider.
This can be accomplished by the primary care providers
increasing their knowledge of SSRIs. Also, the primary
care provider should review their own SSRI-prescribing
practices that have developed over time and be aware of
the factors that influence them. The ultimate goal of this
process is to achieve the optimal outcome for the client.
Assumptions
For the purpose of this study, the following
assumptions were made :
1. SSRI-prescribing practice is a phenomenon that
occurs in primary care and is empirically measurable.
2. Primary care providers prescribe SSRIs based on
the provider's perceived level of competence.
Statement of the Problem
The use of SSRIs has become prevalent in primary care
settings across the United States. An increased number of
clients with a diagnosis warranting an SSRI are being seen
in the primary care setting. As these numbers continue to
increase, researchers have identified only minimal
empirical data regarding the SSRI-prescribing practices of
primary care providers. Ongoing investigation of SSRI-
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prescribing practices by health care providers is needed
to ensure safe practices and favorable client outcomes.

Research Questions
This study was guided by the following research
questions :
1. What are the factors that influence the
prescribing practices of primary care providers regarding
SSRIs?
2. What is the perceived competency level of primary
care providers in prescribing SSRIs?
Definitions of Terms
The terms defined for this research study were as
follows :
Factors: Theoretical : any of the conditions, e t c .
that bring about a result

{Webster's New World Dictionary,

2002) . Operational : any condition that brings about a
result of influencing a primary care provider to choose
one treatment over the other as defined by the Dowell
Prescribing Questionnaire.
Prescribing practices: Theoretical: the process
undergone in which one orders or advises the use of a
medicine or treatment
1995).

{Webster's New World Dictionary,

Operational: the process in which the primary care
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provider orders or advises an SSRI as measured by the
Dowell Prescribing Practice Questionnaire.
Primary care providers: Theoretical : an advanced
practice nurse or medical doctor who is educated in the
care of patients with emphasis in primary care
Heritage Dictionary,

2002).

(American

Operational: those physicians

and nurse practitioners educated to make health care
services available in a primary care setting and are
listed in a local public guide to physicians and nurse
practitioners.
SSRIs: Theoretical: a class of drugs that inhibits
the reuptake of serotonin by neurons of the central
nervous system and are primarily used in the treatment of
depression

{American Heritage Dictionary, 2002).

Operational: a class of drugs that inhibits the reuptake
of serotonin by neurons of the central nervous system and
are primarily used in the treatment of depression by
primary care providers. This class includes the following:
citalopram,

fluvoxamine, paroxetine,

fluoxetine,

sertraline, and escitalopram.
Perceived competency level: Theoretical: the level at
which one feels capable

{Webster's New World Dictionary,

1995). Operational: a primary care provider's level at
which one feels capable of prescribing SSRIs as measured
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in the participants'

responses to questions 10-11 on the

Dowell Prescribing Practice Questionnaire.
Summary
The SSRI-prescribing practices among nurse
practitioners and physicians in a southeastern state are
presently unknown. This study sought to determine the
SSRI-prescribing practices of primary care providers in
this area. In this chapter, an introduction to this
research problem was provided. Benner's Theory of Novice
to Expert was described as the theoretical foundation for
the study.
Chapter II contains literature that was reviewed
pertaining to this study. Chapter III explains the
empiricalization of the problem and describes the setting,
population,

and sample. Chapter IV discusses the findings

of the research data. Finally, in Chapter V an explanation
of the findings and the conclusions drawn from the
findings are revealed, along with implications for
nursing.

Chapter II
Review of the Literature
A review of the literature was conducted to explore
the SSRI-prescribing practices in primary care. To date,
research regarding this topic remains limited. SSRI use is
growing in the field of primary care. Although many
studies have been carried out concerning the use of SSRIs,
no research studies were identified regarding the SSRIprescribing practices of primary care providers.
Antidepressants are among the most frequently
prescribed drugs in the world.

In 2001, Shell conducted a

study concerning the prescribing practices of
antidepressants by nurse practitioners. The purpose of
this study was to determine the factors nurse
practitioners consider when prescribing an antidepressant,
antidepressant-prescribing frequency by nurse
practitioners, types of antidepressants prescribed by
nurse practitioners, and health problems that nurse
practitioners are treating with antidepressants.

Shell

also sought to determine nurse practitioners' perceived
competence in choosing an appropriate antidepressant and
14
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their perceived need for further education about
antidepressants.
The researcher implemented a survey design. The
researcher developed a 2 6-item questionnaire that was used
to attain information pertaining to the prescribing
practices of nurse practitioners. The questionnaire was
reviewed by a group of nurse practitioners selected by the
researcher and revisions were made to the questionnaire in
accordance with a small pilot study. The questionnaire was
mailed to 108 nurse practitioners from Tennessee. They
were randomly chosen from a database of 541 nurse
practitioners.

For the purpose of this study, the nurse

practitioner must practice at least 30 hours a week in
direct patient care and must have drug-prescribing
privileges. A total of 70 questionnaires were returned,
yielding a 65% return rate; 44 (63%) of the returned
questionnaires met the study's inclusion criteria

(Shell,

2001). Data were analyzed using descriptive statistics.
Shell

(2001)

found nurse practitioners reported writing

between 1 and 100 prescriptions per week for
antidepressants. The respondents were asked to give the
average length of time, in consecutive weeks, that they
prescribed treatment with antidepressants, and the
response ranged from 6 to 52 weeks. Approximately half of
the respondents

(53%) reported consecutive treatment of 24

16
weeks or less, and 22% of the respondents reported
consecutive treatment of 12 weeks or less
Factors influencing the practitioners'

(Shell, 2001).

choice of

antidepressant were measured on a Likert-type scale. The
certain factors were ranked from no influence to most
important. The results indicated efficacy (68%) and the
nurse practitioner's knowledge of the antidepressant
as being the most influential factors. Cost factors
potential for drug interaction
associated medical conditions

(42%)
(61%),

(66%), and the patient's
(66%) were ranked closely

behind as being very important. Media advertising
and pharmaceutical promotional efforts

(72%)

(55%) were found to

be of minimal influence on a nurse practitioner's choice
of an antidepressant. The most frequently prescribed
antidepressants by the respondents were Prozac
Paxil

(43%) and

(39%). The most frequent mental health disorders

treated by the respondents were depression
social phobia/panic

(91%) and

(45%). Seventy-one percent of the

practitioners involved in the study felt confident in
choosing the antidepressant best suited for the patient's
condition. Twenty-nine percent did not feel comfortable
with choosing an antidepressant. The study also revealed
that 56% of the respondents felt that they needed to be
further educated on antidepressants.

It was found that

when prescribing antidepressants, there was a variation
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among the respondents and their prescribing practices and
in some cases variation from established guidelines.
Shell

(2001) concluded that nurse practitioners

frequently treat mental health disorders and prescribe
antidepressants for a variety of health disorders. The
results of the study indicate that nurse practitioners
need more education about the appropriate selection and
use of antidepressants

(Shell, 2001) . Shell also concluded

that nurse practitioners need to seek continuing education
on antidepressants and adhere closely to established
practice guidelines on antidepressant use and treatment of
depression.
The findings of this study are important to the
current study because the type of research implemented by
Shell is congruent with the type of information this
researcher is seeking: primary care providers and their
prescribing practices with SSRIs. Assessing the
prescribing practices of antidepressants by nurse
practitioners is very crucial in optimally caring for
patients in the primary care setting.
Another study, Stafford, MacDonald, and Finkelstein
(2001), reported more than 19 million adults are affected
annually by depression in the United States. Depression
can be adequately treated with medications. Antidepressant
pharmacotherapy assists between 65% and 7 5% patients in
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dealing with depression. There are three classes of
antidepressants: tricyclic and related cyclic
antidepressants

(TCAs), monoamine oxidase inhibitors

(MAOIs), and selective serotonin reuptake inhibitors
(SSRIs). Among these medications,

SSRIs have the most

favorable side affect and safety profiles, characteristics
likely to increase their prescription by physicians and
continue use by patients

(Stafford et al., 2001).

In 2001,

Stafford et al. investigated trends in antidepressant use,
as well as broader changes in depression treatment,
following the availability of SSRIs.
Data used in this study originated from the National
Disease and Therapeutic Index

(NDTI), a continuing

physician survey conducted by IMS HEALTH. The NDTI
provides information pertaining to the diagnostic and
prescribing information of patients seen in clinics
throughout the United States. A random sample of officebased physicians stratified by specialty was selected from
the masterlists of the American Medical Association
(Chicago,

IL) and the American Osteopathic Association

(Chicago,

IL)

(Stafford et al., 2001). Practice patterns

are revealed using this sample. The sample population
consisted of approximately 3,500 physicians. Each
physician was assigned a 2-day data collection period each
quarter. Data for this study were collected from NDTI
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reports gathered from 1987 through the third quarter of
2001. Stafford et al.

(2001) selected visits by patients

reported to have depression-related diagnosis. Outcomes
examined included the frequency of depression visits, the
likelihood of antidepressant therapy, and the use of
specific medications

(Stafford et al., 2001).

Data were analyzed using descriptive statistics. The
number of patients reporting depression during an office
visit increased from 14.4 million a year in 1987 to 24.5
million a year in 2001.

In accordance with these results,

other variations occurred. The number of visits made to
psychiatrists declined from 44% of visits in 1987 to 29%
in 2001. The number of visits to primary care physicians
also increased during this time period from 50% to 64%.
The ages of patients also decreased. The most evident
decline was in the age group of 65 and older. Women
consistently made up two thirds of the patients seen
during this time period. Stafford et al.

(2001) determined

that among patients reported to have depression, the rate
of antidepressant medication treatment steadily increased
from 70% of patients in 1987, 76% in 1990,

87% in 1996,

and 89% in 2001. In 1987, tricyclic antidepressants

(TCAs)

were used most often in treating depressed patients.
Physicians reported the use of a TCA in 47% of visits by
patients with depression, with Amitriptyline

(14% of
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depression patients), doxepin

(7.7%), and desipramine

(63%) the most commonly prescribed TCAs

(Stafford et al.,

2001). The most common non-TCA antidepressant during this
time was trazedone.

It was reported as being used 12% of

the time in 1987. The first SSRI,

fluoxetine, was

introduced in January of 1998. During the first year
fluoxetine was on the market,
depression received the drug

9.7% of patients with
(Stafford et al., 2001). The

following year, fluoxetine was prescribed to 21% of
depressed patients seen. SSRI use increased to 46% by
1993. This occurred after two other SSRIs were introduced;
sertraline was introduced in 1992 and paroxetine in 1993.
Subsequent release of venlafaxine

(1994),

fluvoxamine

(1995), and citalopram (1998) increased SSRI use still
further to 53% in 1994, 64% in 1997, and 69% in 2001
(Stafford et al., 2001). As the use of SSRIs increased,
the use of other antidepressant medications decreased. The
use of TCAs decreased from 47% in 1987 to 2.1% in 2001.
The MAOIs have been used very little throughout the time
period researched. Benzodiazepines also have declined from
use. In 1987, 21% of depressed patients were treated with
benzodiazepines.

In 2001 only 2% were treated with

benzodiazepines.
The methods of managing depression went through
significant changes from 1987 to 2001.

Stafford et al.
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(2001)

concluded that the increasing therapeutic dominance

of SSRIs may have contributed to other changes in
depression treatment,

including declining benzodiazepine

use, increased aggregate antidepressant treatment rates,
and increased reporting of depression. The authors of this
study suggest that SSRIs side effect profiles and the
perceived effectiveness of SSRIs may be the contributing
factors to the above changes.
The introduction of SSRIs has brought many changes to
the prescribing practices of physicians who manage
depression. The findings of this study are important to
this current author's application of research study
because of the impact that SSRIs made on the prescribing
practices of medications used for depression. Stafford et
al.'s study also is important to this author's study
because the findings reveal the increased use of SSRIs in
the United States. Thus, there is the need for further
research concerning the prescribing practices of SSRIs.
Stafford, Ausiello, Misra,

and Saglam (2000) reported

depression as the number one cause of morbidity in the
United States. The primary care role in treating
depression has been altered due to the changes in the
organization of health care. Insurance companies have been
discouraging health care providers from referring patients
with depression to a specialist. As a result, almost half
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of all patients with affective disorders are seen in
primary care settings

(Stafford et al., 2000). Primary

care providers have access to treatment of depression, but
past studies have signaled that depression is
underdiagnosed and undertreated by this group of health
care professionals. Other studies, however,

suggest that

primary care physicians have begun to meet the new
challenges they face in the treatment of depression
(Stafford et al., 2000). In 2000, Stafford et al. sought
to expand on the existing literature by investigating the
use of pharmacotherapy and counseling by primary care
physicians to examine whether improvements in depression
management have continued.
Stafford et al.

(2000) reported that 1,322 primary

office visits by patients reported to have depression were
analyzed. Data were collected by an ongoing survey that
ensures random, stratified sampling by geographic area and
specialty. The patients were 18 years of age and older and
were seen by internists, general practitioners, or family
physicians. The patterns of medication and physician
counseling were examined. Antidepressants were categorized
into one of the following classes: MAOs, TCAs, SSRIs, or
other antidepressants

(including bupropion, trazodone, or

the nonspecific designation "antidepressant agent"). The
authors reported that their assessment of counseling
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practices focused on the report of either psychotherapy or
mental health counseling during physician visits. The
patients' diet, exercise, weight reduction, injury
prevention,

and smoking cessation were also evaluated

because the presence of depression may complicate the
management of these issues.

Independent predictors of

depression therapy were examined using multiple logistic
regression. Where informative, the authors compared the
practices of primary care physicians with those of
psychiatrists.
For each visit record, the National Center for Health
Statistics provided a visit weight calculated from the
physician and visit sampling rates, adjusted for
nonresponse.

Statistical aggregation using these visit

weights allowed the researchers to estimate the national
volume of clinical activities among office-based
physicians. These weights were further modified by
proportional scaling to provide "effective sample sizes."
Using SAS, bivariate differences were tested using the
chi-square test with a p value < .05 signifying
statistical significance

(Stafford et al., 2000).

Stafford et al. found that 7.8% of the primary care
office visits were related to a diagnosis of depression.
Antidepressants

(42%) were found to be the most common

form of treatment,

followed by psychotherapy/mental health
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counseling

(28%) and benzodiazepines

(21%). SSRIs

(25.8%)

were found to be the most prescribed antidepressant by
primary care providers. TCAs
antidepressants

(10.7%) and other

(7.9%) were the next most commonly

prescribed medications.
SSRI use for depression was reported more frequently
among patients 18 to 44 years old (33.3% of all depression
visits)

compared with those 45 to 64 years old

patients 65 years or older

(20.6%) and

(23.0%, p < .001). Among the

different primary care specialties, SSRIs were noted more
often by family physicians

(32.8%) than by internists

(22.6%) or general practitioners

(19.2%, p < .001). TCA

use was not significantly related to patient age. General
practitioners prescribed TCAs more often
internists

(8.3%) or family physicians

(23.4%) than

(6.4%, p < .001)

(Stafford et al., 2000).
The use of benzodiazepines and antidepressants varied
among primary care specialty. The use of benzodiazepines
was influenced by health insurance and geographic region.
The researchers found that psychiatrists reported
psychotherapy/mental health counseling
frequently,

followed by antidepressants

benzodiazepines

(88%) most
(64%) and

(25%).

The p r e d o m i n a n t use of SSRIs suggests that p r i m a r y
care p h y s i c i a n s have be gun to adopt new t h e r a p e u t i c
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strategies for depression.

Furthermore,

the researchers

found the frequent use of benzodiazepines disturbing.

In

59% of the visits to primary care physicians, where
depression was diagnosed and benzodiazepines were ordered,
anxiety was not addressed.

Stafford et al.

(2001) found

the overall use of antidepressants to be significantly
lower in comparison to prior studies.
This study is of significance to the author's study
because this type of research is parallel with the type of
research that the author is implementing. The frequent use
of SSRIs in primary care reported in this study is also of
great interest to the researcher, considering the SSRI
prescribing practices of primary care providers was the
focus of the current researcher's study. These researchers
also reported that psychiatrists prescribed
psychotherapy/mental health counseling more often than
they prescribed a medication. This is also of interest to
the current author.
Ferguson

(2000) conducted a study to review the

diagnosis and treatment of depression in primary care.
Depression, one of the most common disorders in the
primary care setting,

is a serious mental illness with an

estimated lifetime prevalence rate of 17%. Many patients
with depression first seek help from their primary care
physician,

complaining of a variety of somatic symptoms
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that actually mask a depressive disorder

(Ferguson, 2000).

Patients may return repeatedly to their primary care
physician seeking resolution of their symptoms, but,
despite these repeated visits, only 50% of patients with
depression who are seen in the primary care setting will
be accurately diagnosed, and, of these, less than 10% will
be appropriately treated (Ferguson, 2000).
Ferguson reviewed relevant articles on depression
retrieved from Medline. They were classified into the
following categories: diagnosis and screening,
nonpharmacologic therapy, pharmacologic therapy, newer
antidepressant agents, and maximizing antidepressant
therapy. The importance to primary care practice was
considered in determining the significance of each article
reviewed.
Ferguson

(2000) reported that because no laboratory

tests exist for depression and no biological markers can
be measured routinely, the diagnosis of depression must be
made with a number of reliable depression scales and
questionnaires that can be completed quickly in the
primary care setting

(e.g., Zung Self-Rating Depression

Scale, Beck Depression Inventory, or Geriatric Depression
Scale).
The goal of depres s i o n trea t m e n t is to lead the
p a t i e n t to r e c overy and a l l e v i a t e all symptoms.

Treatment
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should encompass methods that rapidly relieve symptoms
(e.g., pharmacotherapy)

and prevent relapse and recurrence

(e.g., nonpharmacologic therapy and or pharmacotherapy).
Advances in the treatment of depression, which include new
agents with dual mechanisms of action and a broader
spectrum of efficacy across affective and anxiety
disorders, make these goals obtainable

(Ferguson, 2000).

The researcher identified the need for psychotherapy and
patient education when treating a patient with major
depressive disorder. Psychotherapy includes cognitive,
behavioral, and interpersonal therapy. This type of
therapy must be performed by a qualified mental health
professional. The primary care physician can perform a
counseling role by providing the patient with support and
insight, offering alternative explanations, and making
recommendations. The primary care physician may also
educate the patient on the biochemical nature of
depression and reassure the client that the symptoms are
not due to a personal weakness.
Increased knowledge about the diagnosis and treatment
of depression has greatly enhanced the ability of the
primary care physician to provide safe and effective
pharmacological therapy (Ferguson, 2000). Ferguson
reported that TCAs and MAOIs are no longer considered the
treatments of choice because of the severity of side
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effects and the potential for fatalities. SSRIs have been
found to have fewer side effects and are tolerated better
than TCAs and MAOIs.
Patients are capable of attaining remission with the
appropriate treatment. To ensure that patients attain
remission and have a low risk of relapse and recurrence,
pharmacotherapy should be maintained at the maximum
tolerated dose for at least 4 to 9 months. Thereafter,
long-term maintenance therapy should be instituted to
prevent the development of a new episode

(Ferguson, 2000).

Ferguson concluded that patients can be diagnosed
rapidly with any one of several reliable questionnaires
that can be administered at the office. These
questionnaires should become a routine part of the primary
care physician's practice, much like blood pressure
monitoring

(Ferguson, 2000). Once a diagnosis is reached,

the appropriate therapy must be selected. An understanding
of the risk-benefit profiles, adverse events, drug-drug
interactions, and onset of action of these antidepressant
agents is critical for appropriate management of depressed
patients

(Ferguson, 2000).

Ferguson's

(2000) study relates to the current

researcher's endeavor, which focused on the prescribing of
SSRIs for depression treatment in primary care. Ferguson
(2000) concluded that depression is one of the most common
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disorders treated in primary care today. The author
reported that patients can be treated safely and
successfully in the primary care setting with
pharmacological treatment,

if adequately diagnosed. The

current author's study congruently sought to reveal
diagnostic methods and treatment options concerning the
prescribing of SSRIs in primary care.
Dowrick, Gask, Perry, Dixon, and Usherwood
sought to determine if general practitioners'

(2000)

(GPs)

attitudes toward depression predict their clinical
behavior. General practitioners'

attitudes toward

depression vary, as do their abilities to detect and
manage it effectively (Dowrick et al., 2000). The
researchers tested two hypothesis:

(a) That questionnaire

measures of GPs' confidence in identifying depression
predict their ability to identify depression in their
patients and (b) that GPs who prefer antidepressants
prescribe more than those who prefer psychotherapy.
Depression is a common and disabling condition,

for

which the overwhelming majority of medical care is
provided by general practitioners. The Depression Attitude
Questionnaire

(DAQ) has been designed within this context

as an instrument to enable researchers to measure doctors'
attitudes to depressive illness, and thereby as a means to
orientate educational effort

(Dowrick et al., 2000). The
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DAQ is a self-completion instrument consisting of 20
questions. Answers are analyzed using a visual analogue
scale.

Factor analysis indicated that 17 of the items fall

into 4 principal components. These components include
attitudes toward treatment, professional unease,
depression malleability, and identification of depression.
The DAQ has been promoted as a valid and reliable measure
of the attitudes of GPs toward depression

(Dowrick et al.,

2000).
Forty GPs completed the DAQ and were asked for
prescribing information. Between November 1996 and March
1997, two research assistants undertook waiting-room
surveys of consecutive attenders at each of these GP's
offices

(Dowrick et al., 2000). Attenders ranged from age

16 to 65 years. They were asked to answer the 12-item
General Health Questionnaire

(GHQ-12). After the

consultation, the GP rated each patient on the severity of
psychological disturbance along a 5-point Likert scale
ranging from "no disorder" to "severe disorder." The DAQ
was also completed by the GPs. The GPs also agreed to have
their prescribing patterns reviewed by the research team.
From a comparison of the GHQ-12 and doctor rating scores
for each patient,

it is possible to make three differing

assessments of a doctor's ability to diagnose depression
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and related psychological disorders,
identification, accuracy, and bias
Dowrick et al.

in terms of

(Dowrick et al., 2000).

(2000) reported a total of 1,436

general practice attenders. All 40 general practitioners
completed the DAQ and achieved adequate numbers of
severity ratings to allow identification,

accuracy,

and

bias ratings to be calculated for each GP. Component 1
scores were grouped around the mean, while the Component 3
depression malleability scores were skewed to the left.
The mean DAQ score for Component 3 suggests that most of
the general practitioners did not believe that depression
was an inevitable condition, while the scores for the
other three components indicated a more even distribution
of attitudes. The researchers indicated that GPs who felt
comfortable with depression were more likely to identify
it accurately. Similarly, GPs who considered that
depression is a malleable condition were more likely to
identify it accurately. However, there were significant
associations between observed diagnostic ability and
preference for psychotherapy, ease in managing depression,
and belief in successful treatment.
PACT data

(prescribing information) was available for

26 (65%) of the GPs for the time period of the study. The
mean number of anxiolytics and hypnoticé during this time
was 203. The average number of prescriptions written for
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antidepressants at this time was 207. Among the
antidepressants, the mean number of prescriptions issued
for tricyclics was 118, versus 86 for the SSRIs. An
association was found between the GPs' attitudes toward
treatment and the prescribing of SSRIs. No association was
detected between the other three components of the DAQ and
the GPs' number of prescriptions for antidepressants in
general or either tricyclics or SSRIs in particular.
Dowrick et al.'s

(2000) study demonstrated the

influence that general practitioners'

attitudes have on

their treatment of depression. The current study focused
on the SSRI prescribing practices of primary care
providers when treating depression.

It is important to

understand what factors influence health care providers
when making treatment choices.
Patients with depressive symptoms are more likely to
seek help in the primary care setting than any other
health care environment. Observational studies continue to
demonstrate, however, that the outcomes of patients with
depression managed in primary care are less than optimal.
Disease detection rates are low, the intensity of
treatment is usually inadequate, and patients are often
left with significant clinical and functional impairments
(Finley et al., 2002). In 2002, Finley et al. carried out
an investigation to study the effect of a clinical
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pharmacy specialist working along with primary care and
psychiatry in the treatment of depression.
This investigation was conducted at KPMCSR, a medium
sized primary care facility within a large nonprofit staff
model health maintenance organization

(HMO). The clinic is

staffed by approximately 30 primary care physicians
physicians and 2 nurse practitioners)
care to over 52,000 members

(28

and provides medical

(Finley et al., 2002).

Thirteen PCPs referred eligible patients to the
intervention group. The two pharmacists involved in the
study had their doctor of pharmacy degrees and had
experience in direct patient care. The pharmacists were
given limited prescribing privileges. They were granted
permission to modify medications previously prescribed for
the patient and to add ancillary medications if needed.
The pharmacists were required to notify the PCP before
making changes to the treatment regimen.
The patient population consisted of HMO members who
were identified by their PCP as suffering from depression
and subsequently received prescriptions for antidepressant
medications for this purpose.

Patients in the control

group consisted of HMO members who were treated for
depression with antidepressants by the remaining 17 PCP at
this facility in accordance with the usual standard of
care

(Finley et al., 2002). Demographic variables.
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treatment patterns,

sex, age, and medical co-morbidity

were reviewed.
The 13 providers who participated in the
collaborative practice model were encouraged to refer all
patients diagnosed with depression and started on
antidepressant medications to the pharmacist-managed
clinic for medication management and follow-up

(Finley et

al., 2002). The PCP notified the pharmacists at the
conclusion of each index visit. The pharmacists
interviewed the patient on the day the antidepressant was
prescribed. This interview was congruent with a
psychiatric interview. The first half of the interview
gathered data concerning symptoms, current environmental
stressors, previous mental health history, medical
history,

social history, and family history. The latter

half of the interview was devoted to patient education
regarding the nature of depression as an illness
(predisposing factors, natural course, prognosis, and
anticipated recovery process), pharmacological treatment
for depression

(potential adverse effects, drug

interactions, therapeutic response pattern, and duration
of treatment), and the importance of adhering to the
treatment

(Finley et al., 2000). Patients were followed by

return visits and telephone calls.
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Baseline differences between the treatment and
control groups were compared using Student's t test for
continuous data and the chi-square test for categorical
data

(Finley et al., 2000). The baseline 6-week and

baseline 24-week values were compared using a Student's t
test.
The intervention group consisted of 91 patients.
There were 12 9 patients identified in the control group.
Analysis of the antidepressant initially prescribed by
PCPs at baseline revealed that the vast majority of
patients in both groups received SSRIs,

85.1% in the

intervention group versus 92.2% in the control group, with
starting doses slightly lower in the intervention group
(Finley et al., 2000). Both groups expressed satisfaction
in their overall care.
Finley et al.

(2000) reported that a collaborative

practice model in which clinical pharmacy specialists
worked with PCPs and managed the medication therapy of
patients with mild to moderate depression for 6 months
increased patients' adherence to treatment and their
satisfaction and reduced the patients'

subsequent visits

to PCPs.
Finley et al.'s study related to the current
researcher's endeavor because from data reviewed it was
evident that SSRIs are frequently used in treating
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depression in primary care. This study provided evidence
that intense management is needed when treating depressed
patients in primary care. The patients'

complete medical,

social, and family history needs to be obtained.
al.

Finley et

(2000) also discovered that education of patients

concerning depression and their treatment plays a major
role in patients'

compliance.

Summary
From the review of literature,

it is evident that

SSRI usage is steadily increasing in the primary care
setting. The review of literature supported the importance
of researching the antidepressant prescribing practices of
primary care providers. Researchers compared the
prescribing practices of primary care providers to that of
psychiatrists.

Differences were noted, signaling the need

for the investigation of primary care providers'

SSRI-

prescribing practices. Treatment options of depression
were researched,

along with other methods of managing this

disorder. The review of literature also gave insight on
the competence level of primary care providers. Primary
care providers should be highly educated in the arena of
depression and the treatment options in order to optimally
care for their patients.

Chapter III
The Method
The purpose of this study was to determine the SSRIprescribing practices of primary care providers.
Empiricalization of the problem will be described in this
chapter. The setting, population, and sample will be
described,

and the methods utilized to collect the data

will be explained.
Design of the Study
A descriptive survey research design was implemented
to identify the SSRI-prescribing practices of primary care
providers. Gillis and Jackson (2002) defined a descriptive
design as research that identifies and describes concepts
and phenomena of interest to nursing. This research design
was appropriate because the purpose of the research was to
identify the SSRI-prescribing practices of primary care
providers. No manipulation of variables occurred.
Setting, Population^ and Sample
The setting for the study was primary care health
sites in a southeastern state. The target population
37
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consisted of 2,000 physicians and nurse practitioners who
practice in a primary care setting and who are listed in a
public physician and nurse practitioner directory. A quota
sampling method was used to reduce the target sample size
to 100. Surveys were sent to the first 50 physicians and
the first 50 nurse practitioners listed as primary care
providers. The final sample consisted of those primary
care providers who responded to the survey and returned
the questionnaires.
Instrumentation
Two instruments were used to collect data for the
study.

The first instrument was the researcher-designed

Demographic Survey, which was used to assess
characteristics of the sample

(see Appendix A ) . The survey

consisted of five questions that participants were
instructed to check or to fill in the most appropriate
responses.

Items were constructed to elicit information

pertaining to the specific profession and to the length of
practice of the participant.
The second research instrument was the researcherdesigned Dowell Prescribing Practice Questionnaire, which
was utilized to assess SSRI-prescribing practices of
primary care providers

(see Appendix B ) . This

questionnaire contained 11 questions, which participants
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were instructed to check the most appropriate responses.
Some examples of questions on the questionnaire are as
follows:

In your role as an MD or NP, approximately how

many patients do you see per day? What methods do you use
to diagnose depression? What treatments other than an
antidepressant do you prescribe? And what factors
influence which SSRI you choose?

Questions 3, 6, and 8

allowed the participant to fill in their response if it
was not listed as an answer choice. A numerical coding
scheme was implemented in order to score the data. Answer
choices were assigned a number code and then arranged on a
graph in accordance with each individual question.
Perceived competency was assessed using items 10 and 11 on
the Dowell Prescribing Practice Questionnaire. A Likert
scale ranging from not competent to very competent was
utilized.

Estimated time to complete the instruments was

10 minutes.
Data Collection Procedure
Protection of the rights of human subjects was
achieved by seeking approval to conduct the study from the
Mississippi University for Women Committee on Use of Human
Subjects in Experimentation

(see Appendix C ) . Packets were

collated and consisted of a letter of introduction and
information concerning consent

(see Appendix D)

the
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Demographic Survey, the Dowell Prescribing Practice
Questionnaire, and a self-addressed,

stamped envelope.

Packets were mailed to 50 primary care physicians and 50
family nurse practitioners in a southeastern state. The
introduction letter advised participants that there were
no risks in participating in the study. The participants
were assured of anonymity by not being required to place
their name on the data sheets. Two weeks after the
questionnaires were sent out, reminder postcards were sent
(see Appendix E ) , Consent was assumed from each
participant by their completion and return of the
Demographic Survey and the Dowell Prescribing Practice
Questionnaire.
Data Analysis
Data from this study were analyzed using descriptive
statistics including means, frequency, distributions,

and

percentages. Content analysis was used to detect common
themes in the data retrieved from questions 3, 6, and 8 if
participants chose to list information not included as an
answer choice. Questions 10 and 11 were analyzed using
percentages.
Summary
In this chapter,
study,

the e m p i r i c a l i z a t i o n of the r e s e a r c h

w h i c h exa m i n e d the S S R I - p r e s c r i b i n g p r a c t i c e s a m o n g
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primary care providers in a southeastern state, was
explained. The design of the study, the setting, the
population,

and the sample were described. The

instrumentation and methods of data collection were
discussed.
addressed.

Finally, the process of data analysis was

Chapter IV
The Findings
The purpose of this study was to determine the SSRIprescribing practices among nurse practitioners in a
southeastern state. A descriptive research design was
implemented. The researcher-developed Demographic Survey
and the Dowell Prescribing Practice Questionnaire were
utilized to collect information from nurse practitioners
and physicians regarding their SSRI-prescribing practices.
Data from each question were analyzed using descriptive
statistics. The findings from the study are presented in
this chapter.
Description of the Sample
A total of 100 surveys were mailed to primary care
providers in a southeastern state. The packet contained
the Demographic Survey and the Dowell Prescribing Practice
Questionnaire. The Demographic Survey consisted of five
questions. The respondents were asked to check their
response to three of the questions and fill in the
appropriate response to answer the other two questions.
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The Dowell Prescribing Practice Questionnaire was made up
of 11 questions. Thirty surveys were completed and
returned to the researcher.
The ages of respondents ranged from 29 to 70 years.
The average age was 43 years. The reported length of time
practicing ranged from 2 to 4 6 years. The average length
of time practicing was 9.9 years. Responses to the other
demographic survey questions are presented in Table 1.
Table 1
Demographic Data Reported by Primary Care Providers
Expressed in Frequency and Percentage

Variable

%

Gender
Female
Male

16
14

53.0
47.0

Ethnicity
African American
Caucasian
Other

1
29
0

3.0
97.0
0.0

Profession
Medical doctor
Nurse practitioner

9
21

30.0
70.0

Note. Percentages rounded to the nearest 10^^
=30.
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Findings Related to the Research Questions
Two research questions guided this study. The first
research question was as follows: What are the factors
that influence the prescribing practices of primary care
providers regarding SSRIs? The second research question
was as follows : What is the perceived competency level of
primary care providers in prescribing SSRIs? Item 1 on the
Dowell Prescribing Questionnaire was designed to assess
how many patients the respondent sees per day. Responses
to item 1 can be found in Table 2.
Table 2
Patients Seen Per Day by Primary Care Providers Expressed
in Frequency and Percentage

No. of patients

%

Less than 10

0

0.0

10 to 15

2

7.0

16 to 20

5

17.0

21 to 25

5

17.0

26 to 30

10

33.0

8

27.0

More than 30

Note. Percentages were rounded to the nearest 10^^
^N = 30.
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Item 2 was designed to find the percentage of
patients seen that suffer from depression. Among the
respondents,

8 (27%) answered less than 15%,

16 (53%)

answered 25%, 5 (17%) answered 50%, 1 (3%) answered 75%,
and none of the respondents answered more than 75%.
Item 3 was utilized to find what methods the primary
care providers are using to diagnose depression.
Respondents were encouraged to check all that apply as
well as to write in additional methods. The most common
methods for diagnosing depression may be seen in Table 3.
Table 3
Most Common Methods Used to Diagnose Depression Expressed
in Frequency and Percentage
Diagnosing method

%

DSM-IV criteria

15

50.0

Established quantitative
screening tool for depression

13

43. 0

Patient states, "I am depressed."

20

67.0

Patient presents with symptoms
of depression

28

93.0

9

30.0

Other

Note. One respondent failed to respond. Respondents were asked
to select as many diagnosing methods as applied and to write in
other methods if they were not included in the list. Additional
methods that were listed are as follows: Zung Depression Scale,
in-house questionnaire, family history of mood disorders, known
somatization, refer to in-house therapist, how patients present
to office, patients' state of mind, and SIGE CAPS
questionnaire.

'N = 30.
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Item 4 was designated to determine the percent of
patients treated with an SSRI, considering the number of
patients the responders treat for depression. Respondents
were asked to choose the percentage that reflected their
prescribing practices. There were only 29 responses to
this question. Results of item 4 are presented in Table 4
Table 4
Percentage of Patients Treated with an SSRI by Frequency
and Percentage

Percent treated with SSRI

f^

%

Less than 25

2

7.0

25

2

7.0

50

5

17.0

75

9

31.0

11

38.0

More than 75

Note. Percentages were rounded to the nearest 10^^.
^N = 30.
Item 5 was designed to assess the most often
prescribed SSRI to the least prescribed SSRI. Respondents
were asked to rank the six SSRIs in order of their most
prescribed to the least prescribed. Escitalopram was the
most often prescribed SSRI, while fluovoxamine was the
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least often prescribed. Responses to item 5 are presented
in Table 5.
Table 5
Frequently Prescribed SSRIs Expressed in Frequency and Percentage

2

1*
f

SSRI

%

3

f

%

f

4
%

f

5
%

f

6^
%

f

%

citalopram

3

12.0

1

27.0

5

19.0

6

23.0

5

19. 0

fluovoxamine

0

0.0

0

0.0

0

0.0

0

0.0

4

15.0

paroxetine

6

23.0

8

31.0

11

42.0

0

0.0

1

4.0

0

0.0

fluoxetine

2

8.0

1

4.0

3

12.0

3

12.0

16

62.0

1

4.0

sertraline

6

23.0

9

35.0

3

12.0

6

23.0

2

8 .0

0

0.0

escitalopram

8

31.0

5

19.0

7

27.0

1

4 .0

5

19. 0

0

0.0

0

0.0

22 85.0

Note. Only 26 respondents ranked all six drugs on this question.
Incomplete rankings of the drugs are not included in this table.
®1 = Most often prescribed. ^6 = Least often precribed.

Item 6 was designed to assess what factors influence
which SSRI a primary care provider chooses. Responses to
item 6 can be found in Table 6. Findings revealed that
side effects of the medication were most influential.
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Table 6
Factors Influencing the SSRI-Prescribing Practices of
Primary Care Providers Expressed in Frequency and
Percentage

Factor

f^

%

Cost

19

63.0

Direct to consumer advertising

1

3.0

Drug manufacture influence

4

13.0

Efficacy

22

73.0

Managed care formulary

19

63.0

Patient profile

23

77.0

Side effects

26

87.0

0

0.0

Other

Note. Percentages were rounded to the nearest 10^^.
Participants were asked to "check all that apply," so
percentages total more than 100%.
^N = 30.
Item 7 on the Dowell Prescribing Practice
Questionnaire was designed to elicit whether or not
primary care providers prescribe other types of treatment
before prescribing an antidepressant. Sixty percent
reported that they do prescribe other types of treatment
before prescribing an antidepressant.

Forty percent
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reported that they do not prescribe any other types of
treatment.
Item 8 on the Dowell Prescribing Practice
Questionnaire only applied to those participants who
answered yes to item 7. Item 8 listed types of treatment
for depression other than medication. The participants
were asked to check all that apply. Professional
counseling and exercise were recommended the most
frequently. Responses to item 8 can be found in Table 7.
Table 7
Treatments Prescribed for the Treatment of Depression b y
Primary Care Providers Other Than Medication Expressed in
Frequency and Percentage
Treatment

f^

%

Exercise

9

30.0

Light therapy

2

7.0

11

37.0

Self-help literature

2

7.0

Spiritual counseling

7

23.0

Suicide precautions

3

10.0

Support groups

4

13.0

Other

1

3.0

Professional counseling

Note: Participants were asked to "check all that apply,
so percentages total more than 100%. Percentages were
rounded to the nearest 10^^.
= 30.
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Research Question 2 read as follows: What is the
perceived competency level of primary care providers in
prescribing SSRIs? Items 10 and 11 on the Dowell
Prescribing Practice Questionnaire were designed to elicit
answers to this question.

Item 10 asked respondents to

rate themselves regarding how competent they felt
prescribing SSRIs. The ranking scale ranged from 1 (not
competent)

to 4 (very competent).

Among the respondents, none answered not competent or
slightly competent. Nine

of the respondents (32%)

answered

fairly competent, and 19

of the respondents (68%)

answered

very competent. Two of the respondents had no response.
The same question format was also used to assess the
competency level of the respondents regarding answering
client questions related to SSRIs. None of the respondents
answered not competent or slightly competent. Ten of the
respondents

(34%) answered fairly competent, and 19 of the

respondents

(66%) answered very competent. One respondent

did not respond to this question.
To further elucidate findings related to the research
questions,

item 9 on the

Questionnaire stated the

Dowell Prescribing Practice
following : How was the

prescribing of SSRIs covered in your basic medical
education?

The results were as follows : Briefly

44%), moderately

(n = 11,

(n = 6, 24%), and sufficiently (n = 8,
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32%). Four respondents wrote in "none" or "not at all"
rather than selecting any of the three provided options.
These four respondents indicated that they did not cover
prescribing SSRIs in their basic medical education. The
ages of these four participants were 59, 53, 49, and 46
years.
These findings reveal that the majority of the primary
care providers in this study perceive a high level of
competence in prescribing SSRIs. The results also
indicated that the respondents perceive a high level of
competence in answering patients' questions about SSRIs.
Additional Findings
Respondents were also given the opportunity to
express additional comments concerning their prescribing
practices. There were four responses to this part of the
questionnaire. The following are comments collected from
the questionnaire :
A significant number of depressed patients that
I see are bipolar and need mood stabilization
before antidepressant treatment.

SSRIs are frequently prescribed and often very
helpful. It is good that you are studying this.
We had almost no training in depression, yet it
is treated almost as often as colds and
allergies in my experience.

52
Preferred medication for depression in my
practice is Effexor XR.
Summary
Chapter IV presented data obtained from the
Demographic Survey and the Dowell Prescribing Practices
Questionnaire.

Data were analyzed to answer research

questions concerning the SSRI-prescribing practices of
primary care providers in a southeastern state.
Statistical findings were presented. Chapter V contains an
interpretation of the data described in this chapter, as
well as conclusions, implications, and recommendations for
future research.

Chapter V
The Outcomes
The purpose of this study was to determine the SSRIprescribing practices among primary care providers.

SSRIs

are frequently being prescribed in the primary care area.
This researcher posed the following two research
questions :
1. What are the factors that influence the
prescribing practices of primary care
providers regarding SSRIs?
2. What is the perceived competency level of primary
care providers in prescribing SSRIs?
Benner's Novice to Expert nursing served as the
theoretical framework for this study. The sample consisted
of 30 primary care providers ranging in age from 29 to 7 0
years who are currently practicing in a southeastern
state. The respondents,

16 females and 14 males, were

predominantly Caucasian who practice in a primary care
setting. Data for the study were obtained using a
researcher-designed Demographic Survey and the Dowell
Prescribing Practices Questionnaire. Respondents were
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asked to complete the surveys and return them to the
researcher by mail.
Summary of Findings
The sample

{N = 30) used in this study consisted of

primary care providers who were randomly chosen from a
public physician and nurse practitioner directory. These
providers were employed in primary care settings in a
southeastern state.
The majority of the respondents reported seeing
approximately 26 to 30 patients a day. Fifty-three percent
of the respondents indicated that of the patients that
they see, 25% suffer from depression.

Diagnosing

depression was most frequently based on the symptoms that
the patient presented with and by the patient stating,
"I'm depressed." Of the patients treated for depression,
the majority of the responders treat more than 75% of
their patients with SSRIs. The most frequently prescribed
SSRI reported was escitalopram, with the least often
prescribed SSRI being fluovoxamine. Respondents reported
that side effects of the drug most often influence which
SSRI they choose. The majority of the providers do not
recommend any other type of treatment before prescribing
an antidepressant. Of the respondents who do, the most
often suggested treatment was professional counseling.
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The majority of the respondents indicated that the
prescribing of SSRIs was covered briefly in their basic
medical education. There were 4 respondents who wrote in
"none" or "not at all" due to SSRIs not existing while
they were in medical school.
Sixty-eight percent of the respondents reported
feeling very competent prescribing SSRIs. Thirty-two
respondents indicated that they felt fairly competent
prescribing SSRIs. There were only 28 responses to this
question. Sixty-six percent of the respondents felt very
competent answering patient questions about SSRIs. Thirtyfour percent reported feeling fairly competent answering
patients' questions.
Discussion
Findings for the first research question. What are
the factors that influence the prescribing practices of
primary care providers regarding SSRIs?, revealed that 93%
of the respondents diagnose depression by the patient's
presenting symptoms. Ferguson (2000) reported that because
no laboratory tests exist for depression and no biological
markers can be measured on a routine basis, the diagnosis
of depression must be made using reliable depression
scales and questionnaires that can be completed quickly in
the primary care setting. Sixty-seven percent of the
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respondents in the current study also reported diagnosing
a patient with depression if the patient states, "I'm
depressed."
Shell

(2001)

found variation among the respondents

prescribing practices of antidepressants and in some cases
variation from established guidelines. The findings are
significant because this study also found variation in the
diagnosing and treatment of depression. The Shell

(2001)

study also reported 56% of the respondents felt that they
needed to be further educated on antidepressants. Of the
respondents in the current study,

44% reported being

educated on the prescribing of SSRIs briefly in their
basic medical education. A lack of education could
contribute to poor patient education and outcome of
treatment. Stafford et al.

(2000) discovered that 7.8% of

primary care visits were related to a diagnosis of
depression. Antidepressants

(42%) were found to be the

most popular choice of treatment.

SSRIs

(25.8%) were found

to be the most often prescribed antidepressant. The
respondents of the current study also reported that SSRIs
(38%) are used more than 75% of the time in treating
depression.
The question, what factors influence which SSRI you
choose?, also indicates one's prescribing practices. The
findings of this question reflected that side effects
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(87%) were the most influential factor. Side effects were
followed closely by the patient profile. Shell's

(2001)

study indicated efficacy (68%) and the nurse
practitioners'

knowledge of the antidepressant

(42%) as

determining factors of which antidepressant they choose.
Cost factors

(61%), potential for drug interaction

and the patients' associated medical questions

(66%),

(66%) were

reported as being the other highly influential factors.
The second question that guided this study, what is
the perceived competency level of primary care providers
in prescribing SSRIs?,

found that all of the respondents

felt either very competent

(68%) or fairly competent

(32%)

prescribing SSRIs. The respondents also reported feeling
very competent

(66%) or fairly competent

(34%) answering

patient questions about SSRIs. These findings are
significant due to the idea that a high competency level
of the primary care provider could contribute to better
patient education, therefore, better patient compliance.
In a similar study. Shell

(2001) reported 71% of the

respondents felt comfortable in choosing an antidepressant
while 2 9 of the respondents did not feel comfortable
choosing an antidepressant.

58
Conclusions
The findings of this study alerted the researcher
that primary care providers are treating more patients
diagnosed with depression than ever before. The majority
of respondents reported that 25% of their patients suffer
from depression. Of those patients, more than 75% are
treated with an SSRI. Escitalopram was the most prescribed
SSRI,

followed by sertaline. Side effects of the drug were

most influential in choosing an SSRI, followed closely by
patient profile. The researcher was interested in the
hastiness of the prescriber to prescribe a medication
before prescribing another type of treatment.
Interestingly, a little more than half of the respondents
recommend that their patient try another type of treatment
before they prescribe the patient an antidepressant. The
treatments most frequently recommended include
professional counseling,

exercise, and spiritual

counseling.
The findings of this study also indicated that
primary care providers perceive a very high level of
competency or feel fairly competent in prescribing SSRIs.
The perceived level of competency of the respondents was
greater than expected by the researcher. The respondents
reported similar competency levels in answering patients'
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questions about SSRIs. Four of the respondents who
reported feeling fairly competent stated that SSRIs were
not developed at the time they were in school. Therefore,
they had no formal education on this class of
antidepressants.
Implications for Nursing
This research sought to explore the SSRI-prescribing
practices of primary care providers. Having knowledge
about their prescribing practices can determine areas in
need of further education. Findings from this study will
provide information that will assist in the optimal
diagnosing and treatment of depression. This study will
reveal knowledge that will have implications for the
primary care provider in the areas of education, practice,
theory, and research.
Education.

Findings from this study revealed that the

majority of primary care providers treat depression with
an SSRI. With this increasing popularity,

information

regarding the use of SSRIs is essential in schools of
medicine and nursing. For personal knowledge, primary care
providers need to participate in continuing education that
would keep them updated on the latest information
regarding SSRIs. Primary care providers must be able to
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educate their patients on SSRIs. Continuing education is
vital in giving patients holistic care.
Practice.

In the primary care setting, primary care

providers must be prepared to initiate and facilitate
conversation regarding the benefits,

contraindications,

and side effects of SSRIs. As the primary care provider
gains knowledge through continuing education,

self-study,

or conferences, protocols may be developed regarding the
prescribing of SSRIs in the primary care setting. The
current study reinforces the importance of primary care
providers increasing their competence levels to ensure
that their patients receive optimal care.
Theory. Benner's

(2001) Novice to Expert Model was an

appropriate framework for this study. The model consists
of five levels that are necessary for a primary care
provider to progress through to acquire competence. These
levels include novice, advanced beginner, competent,
proficient, and expert. Movement through these levels is
accomplished by expanding one's knowledge base by
participating in continuing education and through
experience. This increase in knowledge and experience will
aid in the primary care provider becoming a confident and
competent health care provider. The ultimate goal of this
process is to offer the patient the best care possible.
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Research. This study sought to explore the SSRIprescribing practices of primary care providers.

Findings

from the study revealed that 38% of primary care providers
treat more than 75% of their patients diagnosed with
depression with an SSRI compared with the 7% who prescribe
SSRIs less than 25% of the time. Publication of nursing
research is needed regarding the SSRI-prescribing
practices of primary care providers. The findings of the
research will increase primary care providers'

awareness

of the prescribing practices of other primary care
providers.
Limitations
The survey resulted in a small sample size;
therefore, generalization of the findings beyond the
sample may be impossible. The sampling design was one of
convenience,

thus the sample may not have adequately

represented the characteristics of the population of
primary care providers. Respondents may have interpreted
the questions asked in the survey in different ways. The
accuracy of the data collected may depend upon the
respondents' willingness to share their personal beliefs
and prescribing practices.
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The researcher-designed instruments used to gather
data were assumed to have face validity. The initial use
of these instruments occurred in this current study. The
instruments were self-administered, and data were not
validated.
Recommendations for Further StudyBased on the findings of this study, recommendations
for further study are made. The recommendations are as
follows :
1. Replication of the study using a larger, more
diverse sample of primary care providers,
including primary care providers from other
geographical areas.
2. Conducting research using participants who have
been prescribed an SSRI by a primary care
provider.
3. Education of primary care providers on prescribing
SSRIs in order to provide consistent and optimal
care.
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Demographic Survey
Please check

(%/) and or fill in the appropriate responses

1. Age:_________
2. Gender
O a . Female
O

b . Male

3. Ethnicity
O a. African American
O

b. Caucasian

O

c . Other. Please specify

4 . Specify profession
Ü a. Medical doctor
O

b . Nurse practitioner

5. Length of time that you have practiced as medical doctor
or nurse practitioner:_____________________________________

APPENDIX B
DOWELL PRESCRIBING PRACTICE QUESTIONNAIRE
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Dowell Prescribing Practice Questionnaire
P lease place a check {/) and or fill in the appropriate responses.
1. In your role a s an MD or NP, approximately how many patients do you s e e
per day?
□

a. < 10

□

b. 10 to 15

□

c. 16 to 20

□ d. 21 to 25
□

e. 26 to 30

□

f. > 30

2. Approximately what percent of the patients that you se e suffer from
depression?
□

a. < 15%

□

b. 25%

□

c. 50%

□

d. 75%

□

e. > 75%

3. What methods do you use to diagnose depression? (Check all that apply)
O a. DSM-IV criteria

d b. Established quantitative screening tool for depression
d
c. Patient states, “I am dep ressed .”
d
d. Patient presents withsymptoms of depression.
d e. Other(s). P lease list:_________________________________________
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4. Considering the patients that you treat for depression, approximately what
percent do you treat with an SSRI?
□

a. < 15%

□

b. 25%

□

c. 50%

□

d. 75%

□

e. > 75%

5. Rank the following SSRIs by circling the number that represents the order of
your most often prescribed to the least often prescribed with 1 being the most
often:
a. citalopram (Celexa)
2 3 4
5 6
b. fluovoxamine (Luvox)

2

3

4

5

6

c. paroxetine (Paxil)

2

3

4

5

6

d. fluoxetine (Prozac)

2

3

4

5

6

e. sertraline (Zoloft)

2

3

4

5

6

f.

2

3

4

5

6

escitalopram (Lexapro)

6. W hat factors influence which SSRI you choose? (Check all that apply)

d a. Cost
d b. Direct to consum er advertising
d c. Drug manufacturer influence
d d. Efficacy
d e. M anaged care formulary
d f. Patient profile
d g. Side effects
d h. Other. P lease list:________________________________________
7. Do you routinely recommend that your patients try other types of treatm ent
before you prescribe an antidepressant?

d a. Yes
□

b. No
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8. If you answ ered “yes” to #7, what other prescribed treatm ents or
recom mendations regarding the treatm ent of depression are being m ade?
(Check all that apply)

d a. Exercise
d b. Light therapy
d c. Professional counseling
d d. Self-help literature
d e. Spiritual counseling
d f. Suicide precautions
d g. Support groups
d

h. Other. P lease specify:________________________________________

9. How w as the prescribing of SSRIs covered in your basic medical education?

d a. Briefly
d b. Moderately
d c. Sufficiently
10.

How com petent do you feel prescribing SSRIs?
1

2

Not
com petent
11.

Slightly
com petent

3
Fairly
com petent

4
Very
com petent

How com petent do you feel about answering patient questions about
SSR Is?
1
Not
com petent

Additional Comments:

2
Slightly
com petent

3
Fairly
competent

4
Very
com petent
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M ississip p i
U n iv e r s it y

FOR^ O M E N _____________________ ( Æ a

A dm itting M en Since 1982

w w w .m uw .edu

March 3, 2003
Ms. Ginger L. Dowell
c/o Ms. Terri Hamill
P. O. Box W-910
Campus
Dear Ms. Dowell:
I am pleased to inform you that the members of the Committee on Human Subjects in
Experimentation have approved your proposed research under the following conditions: (1) that
names be taken off the envelopes; (2) that contact information be furnished so that anyone wanting
the results can write for them and assume responsibility. The Committee was troubled by providing
of lists of primary care providers at random from a pharmaceutical company prescribing lists. This
list would be provided by a drug representative. The Committee felt this might be in violation of
company policy, and they urge you to receive any consents and/or authorizations in writing from
the pharmaceutical company prior to gleaning names from the list.
I wish you much success in your research.
Sincerely,

Vagn K. Hansen, Ph.D.
Provost and Vice President
for Academic Affairs
VH.wr
cc:

Mr. Jim Davidson
Ms. Terri Hamill
Dr. Mary Pat Curtis

Where Excellence is a Tradition
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Dear Survey Participant,
My name is Ginger Dowell. I am a registered nurse currently
enrolled in the masters degree program at Mississippi
University for Women. I am conducting a research study to
determine the SSRI-prescribing practices of primary care
providers. I would like for you to participate in my study.
Your name was chosen from a drug company's prescribing list
of health care providers in West Tennessee.
Participation is voluntary and your confidentiality will be
maintained. You will be asked to fill out a survey regarding
your prescribing practices of SSRIs. You will not be
required to place your name on the survey. The completion
and return of the survey in the self-addressed, stamped
envelope will indicate your agreement to participate in the
study. If you would like results of this study, place your
name and address on the return envelope. Your survey will be
separated from the envelope in order to maintain anonymity.
Thank you for your time and cooperation.
Sincerely,

Ginger Dowell, RN, BSN

APPENDIX E
FOLLOW-UP POSTCARD
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Dear Primary Care Provider,
Thank you for participating in my research
study. Primary Care Providers' Prescribing
Practices of Selective Serotonin Reuptake
Inhibitors. If you have not returned the
Demographic Survey and the Dowell Prescribing
Practice Questionnaire, please do so by June 1,
2003,
Your assistance is appreciated.

Ginger L. Dowell

